Biography

Dr. Sanjeev Kumar Srivastava is currently working as Postdoctoral Fellow at University of South Alabama, USA. He obtained his Ph.D. in Biotechnology from University of North Bengal, India. His main area of interest focuses on Pharmacology and Toxicology, and Molecular Sciences. His area of expertise includes MicroRNA, Genotyping, Therapeutic Target, Cancer Biology, Drug Discovery, Signalling Pathways, and Natural Compounds. He has published 15 articles in journals, and 2 articles in process.

Area of Interest:

Pharmacology and Toxicology

100%

MicroRNA

62%

Cancer Research

90%

Drug Discovery

75%

Natural Compounds

55%

Research Publications in Numbers

Books
0

Chapters
0

Articles
0

Abstracts
0

Selected Publications

Srivastava, S.K., A. Bhardwaj, S. Singh, S. Arora and S. McClellan et al., 2012. Myb Overexpression Overrides Androgen Depletion-Induced Cell Cycle Arrest and Apoptosis in Prostate Cancer Cells, and Confers Aggressive Malignant Traits: Potential Role in Castration Resistance. Carcinogenesis, 33: 1149-1157.
CrossRef | Direct Link |
Pal, Z., P. Antal, S.K. Srivastava, G. Hullam and A.F. Semsei et al., 2012. Non-Synonymous Single Nucleotide Polymorphisms in Genes for Immunoregulatory Galectins: Association of Galectin-8 (F19Y) Occurrence with Autoimmune Diseases in a Caucasian Population. Biochim. Biophys. Acta, Gen. Subj., 1820: 1512-1518.
CrossRef | Direct Link |
Singh, A.P., S. Arora, A. Bhardwaj, S.K. Srivastava and M.P. Kadakia et al., 2012. CXCL₁₂/CXCR₄ Protein Signaling Axis Induces Sonic Hedgehog Expression in Pancreatic Cancer Cells via Extracellular Regulated Kinase- and Akt Kinase-mediated Activation of Nuclear Factor κB. Implications for Bidirectional Tumor-Stromal Interactions. J. Biol. Chem., 287: 39115-39124.
CrossRef | PubMed | Direct Link |
Bhardwaj, A., S. Singh, S.K. Srivastava, R.E. Honkanen and E. Reed et al., 2011. Modulation of Protein Phosphatase 2A Activity Alters Androgen-Independent Growth of Prostate Cancer Cells: Therapeutic Implications. Mol. Cancer Ther., 10: 720-731.
CrossRef | Direct Link |
Srivastava, S.K., A. Bhardwaj, S. Singh, S. Arora and B. Wang et al., 2011. MicroRNA-150 Directly Targets MUC4 and Suppresses Growth and Malignant Behavior of Pancreatic Cancer Cells. Carcinogenesis, 32: 1832-1839.
CrossRef | Direct Link |
Srivastava, S.K., P. Antal, J. Gal, G. Hullam and A.F. Semsei et al., 2010. Lack of Evidence for Association of Two Functional SNPs of CHI3L1 Gene (HC-gp39) with Rheumatoid Arthritis. Rheumatology Int., 31: 1003-1007.
CrossRef | Direct Link |
Singh, S., S.K. Srivastava, A. Bhardwaj, L.B. Owen and A.P. Singh, 2010. CXCL12-CXCR4 Signalling Axis Confers Gemcitabine Resistance to Pancreatic Cancer Cells: A Novel Target for Therapy. Transl. Ther., 103: 1671-1679.
CrossRef | Direct Link |
Agrawal, S., S.K. Srivastava, M. Borkar and T.K. Chaudhuri, 2008. Genetic Affinities of North and Northeastern Populations of India: Inference from HLA-Based Study. Tissue Antigens, 72: 120-130.
CrossRef | Direct Link |
Bharadwaj, U., F. Khan, S. Srivastava, H. Goel and S. Agrawal, 2007. Phylogenetic Applications of HLA Class II Loci. Int. J. Human Genet., 7: 123-131.
Direct Link |